India's Coronavirus Vaccine Market offers growth through government-led initiatives, robust manufacturing, and R&D in vaccine ...

Moderna Inc became the second U.S company to release data from a large study of its experimental vaccine, saying it was 94.5% effective against COVID-19.

A study found that covid-19 vaccines appeared to awaken the immune system in lung and skin cancer patients, helping them live longer than those not vaccinated.

Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines after initial series.

Moderna (MRNA) stock gains as the company beats Q3 2025 forecasts despite lower COVID vaccine sales and narrows revenue ...

Melanoma patients who got an mRNA vaccine for the virus saw median survival times double.

First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. | First, the phase 3 trial of ...

“mRNA vaccine technology has fundamentally changed our ability to respond quickly and precisely to emerging viral threats,” said Johan Neyts, PhD, Director of the GVN Center of Excellence at KU Leuven ...

Moderna ($MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining ...

ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...